{"hands_on_practices": [{"introduction": "The core of G protein signaling is the cyclical transition of the G alpha subunit between an inactive GDP-bound state and an active GTP-bound state. This exercise models this fundamental cycle using mass-action kinetics to establish a steady-state relationship between the rates of activation and hydrolysis. By analyzing the effects of a hypothetical mutation that alters key rate constants, you will gain a quantitative understanding of how changes at the molecular level directly translate into system-level functional outcomes.", "problem": "A G protein-coupled receptor (GPCR) activates a heterotrimeric G protein by catalyzing nucleotide exchange on the guanosine diphosphate (GDP)-bound G alpha subunit, producing guanosine triphosphate (GTP)-bound active G alpha and releasing G beta gamma. Consider a minimal, well-mixed kinetic model with two G alpha states: inactive GDP-bound concentration $[G_{d}]$ and active GTP-bound concentration $[G_{t}]$, with total G alpha conserved as $[G_{\\mathrm{tot}}] = [G_{d}] + [G_{t}]$. The receptor-catalyzed nucleotide exchange occurs with second-order rate constant $k_{e}$ and depends on the concentration of active receptor $[R^{*}]$. There is also receptor-independent basal exchange with first-order rate constant $k_{b}$. Deactivation occurs by GTP hydrolysis, which in the presence of Regulator of G protein Signaling (RGS) proteins is well described as a first-order process with effective rate constant $k_{h}$. Assume rapid reassociation and no other sinks or sources.\n\nStart from mass-action kinetics and conservation to derive the steady-state $[G_{t}]$ under constant $[R^{*}]$. A point mutation in G alpha disrupts the catalytic glutamine involved in GTP hydrolysis, decreasing $k_{h}$ by a factor of $50$, and weakens receptor coupling, decreasing $k_{e}$ by $20\\%$. Basal exchange $k_{b}$ is unchanged. For the wild-type protein, the parameters are:\n- $[G_{\\mathrm{tot}}] = 1.0\\,\\mu\\mathrm{M}$,\n- $[R^{*}] = 0.010\\,\\mu\\mathrm{M}$,\n- $k_{e} = 10\\,\\mu\\mathrm{M}^{-1}\\,\\mathrm{s}^{-1}$,\n- $k_{b} = 1.0\\times 10^{-3}\\,\\mathrm{s}^{-1}$,\n- $k_{h} = 0.200\\,\\mathrm{s}^{-1}$.\n\nCompute the fold-change in steady-state active G alpha concentration produced by the mutation, defined as $F = [G_{t}]_{\\mathrm{mut}}/[G_{t}]_{\\mathrm{WT}}$. Express your answer as a unitless decimal and round your result to four significant figures.", "solution": "The problem is first validated.\n\n**Step 1: Extracted Givens**\n-   Model: Heterotrimeric G protein signaling with two states for G alpha: inactive GDP-bound $[G_{d}]$ and active GTP-bound $[G_{t}]$.\n-   Conservation Law: Total G alpha is conserved, $[G_{\\mathrm{tot}}] = [G_{d}] + [G_{t}]$.\n-   Activation Kinetics:\n    -   Receptor-catalyzed nucleotide exchange: second-order rate constant $k_{e}$, dependent on active receptor concentration $[R^{*}]$.\n    -   Basal, receptor-independent exchange: first-order rate constant $k_{b}$.\n-   Deactivation Kinetics: First-order GTP hydrolysis with effective rate constant $k_{h}$.\n-   Assumptions: Well-mixed system, constant $[R^{*}]$, rapid reassociation of G beta gamma.\n-   Wild-Type (WT) Parameters:\n    -   $[G_{\\mathrm{tot}}] = 1.0\\,\\mu\\mathrm{M}$\n    -   $[R^{*}] = 0.010\\,\\mu\\mathrm{M}$\n    -   $k_{e} = 10\\,\\mu\\mathrm{M}^{-1}\\,\\mathrm{s}^{-1}$\n    -   $k_{b} = 1.0\\times 10^{-3}\\,\\mathrm{s}^{-1}$\n    -   $k_{h} = 0.200\\,\\mathrm{s}^{-1}$\n-   Mutant (mut) Characteristics:\n    -   $k_{h}$ is decreased by a factor of $50$.\n    -   $k_{e}$ is decreased by $20\\%$.\n    -   $k_{b}$ is unchanged.\n-   Objective: Compute the fold-change $F = [G_{t}]_{\\mathrm{mut}}/[G_{t}]_{\\mathrm{WT}}$, rounded to four significant figures.\n\n**Step 2: Validation Using Extracted Givens**\n-   **Scientific Grounding**: The problem describes a standard, simplified mass-action kinetic model for G protein activation and deactivation cycles. This is a fundamental concept in cell signaling and biophysics. All parameters and processes are scientifically sound.\n-   **Well-Posedness**: The problem asks for a steady-state concentration, which is expected to exist and be unique for the given linear kinetic scheme. All necessary parameters are provided to calculate a definitive numerical answer.\n-   **Objectivity**: The language is precise, and the terms are defined within the framework of chemical kinetics. The problem is free of subjective or ambiguous statements.\n\n**Step 3: Verdict and Action**\nThe problem is scientifically grounded, well-posed, objective, and contains sufficient information for a unique solution. Therefore, it is deemed **valid**. We proceed with the derivation and solution.\n\nThe dynamics of the active G protein concentration, $[G_{t}]$, are described by a differential equation based on the principles of mass-action kinetics. The rate of change of $[G_{t}]$ is the sum of formation rates minus the sum of removal rates.\n\nFormation of $[G_{t}]$ occurs from the inactive pool, $[G_{d}]$, through two parallel pathways:\n$1$. Receptor-catalyzed activation, with rate $k_{e} [R^{*}] [G_{d}]$.\n$2$. Basal activation, with rate $k_{b} [G_{d}]$.\nThe total rate of formation is thus $(k_{e} [R^{*}] + k_{b}) [G_{d}]$.\n\nRemoval of $[G_{t}]$ occurs via GTP hydrolysis, a first-order process with respect to $[G_{t}]$:\nRate of removal is $k_{h} [G_{t}]$.\n\nThe complete differential equation for $[G_{t}]$ is:\n$$\n\\frac{d[G_{t}]}{dt} = (k_{e} [R^{*}] + k_{b}) [G_{d}] - k_{h} [G_{t}]\n$$\nThe system is subject to the conservation of total G alpha protein:\n$$\n[G_{\\mathrm{tot}}] = [G_{d}] + [G_{t}]\n$$\nWe can express $[G_{d}]$ in terms of $[G_{t}]$ and $[G_{\\mathrm{tot}}]$:\n$$\n[G_{d}] = [G_{\\mathrm{tot}}] - [G_{t}]\n$$\nSubstituting this into the differential equation yields an equation solely in terms of $[G_{t}]$:\n$$\n\\frac{d[G_{t}]}{dt} = (k_{e} [R^{*}] + k_{b}) ([G_{\\mathrm{tot}}] - [G_{t}]) - k_{h} [G_{t}]\n$$\nAt steady state, the concentration of active G protein does not change over time, so $\\frac{d[G_{t}]}{dt} = 0$.\n$$\n0 = (k_{e} [R^{*}] + k_{b}) ([G_{\\mathrm{tot}}] - [G_{t}]) - k_{h} [G_{t}]\n$$\nTo simplify, let $k_{\\mathrm{act}} = k_{e} [R^{*}] + k_{b}$ be the total pseudo-first-order rate constant for activation.\n$$\n0 = k_{\\mathrm{act}} ([G_{\\mathrm{tot}}] - [G_{t}]) - k_{h} [G_{t}]\n$$\nWe now solve for the steady-state concentration, $[G_{t}]$:\n$$\nk_{\\mathrm{act}} [G_{\\mathrm{tot}}] - k_{\\mathrm{act}} [G_{t}] = k_{h} [G_{t}]\n$$\n$$\nk_{\\mathrm{act}} [G_{\\mathrm{tot}}] = (k_{\\mathrm{act}} + k_{h}) [G_{t}]\n$$\n$$\n[G_{t}] = \\frac{k_{\\mathrm{act}} [G_{\\mathrm{tot}}]}{k_{\\mathrm{act}} + k_{h}}\n$$\nSubstituting the expression for $k_{\\mathrm{act}}$ back gives the general solution for the steady-state concentration of active G alpha:\n$$\n[G_{t}] = \\frac{(k_{e} [R^{*}] + k_{b}) [G_{\\mathrm{tot}}]}{k_{e} [R^{*}] + k_{b} + k_{h}}\n$$\nNow, we apply this formula to both the wild-type (WT) and mutant (mut) cases.\n\nFor the wild-type protein, we use the given parameters:\n$k_{e, \\mathrm{WT}} = 10\\,\\mu\\mathrm{M}^{-1}\\,\\mathrm{s}^{-1}$\n$k_{b, \\mathrm{WT}} = 1.0 \\times 10^{-3}\\,\\mathrm{s}^{-1}$\n$k_{h, \\mathrm{WT}} = 0.200\\,\\mathrm{s}^{-1}$\n$[R^{*}] = 0.010\\,\\mu\\mathrm{M}$\n$[G_{\\mathrm{tot}}] = 1.0\\,\\mu\\mathrm{M}$\n\nThe WT activation rate term is:\n$k_{e, \\mathrm{WT}} [R^{*}] + k_{b, \\mathrm{WT}} = (10\\,\\mu\\mathrm{M}^{-1}\\,\\mathrm{s}^{-1})(0.010\\,\\mu\\mathrm{M}) + 1.0 \\times 10^{-3}\\,\\mathrm{s}^{-1} = 0.1\\,\\mathrm{s}^{-1} + 0.001\\,\\mathrm{s}^{-1} = 0.101\\,\\mathrm{s}^{-1}$\n\nThe steady-state concentration for WT is:\n$$\n[G_{t}]_{\\mathrm{WT}} = \\frac{(0.101\\,\\mathrm{s}^{-1}) (1.0\\,\\mu\\mathrm{M})}{0.101\\,\\mathrm{s}^{-1} + 0.200\\,\\mathrm{s}^{-1}} = \\frac{0.101}{0.301}\\,\\mu\\mathrm{M}\n$$\n\nFor the mutant protein, the parameters are altered as specified:\n$k_{e, \\mathrm{mut}} = k_{e, \\mathrm{WT}} \\times (1 - 0.20) = 10 \\times 0.8 = 8.0\\,\\mu\\mathrm{M}^{-1}\\,\\mathrm{s}^{-1}$\n$k_{h, \\mathrm{mut}} = \\frac{k_{h, \\mathrm{WT}}}{50} = \\frac{0.200\\,\\mathrm{s}^{-1}}{50} = 0.004\\,\\mathrm{s}^{-1}$\n$k_{b, \\mathrm{mut}} = k_{b, \\mathrm{WT}} = 1.0 \\times 10^{-3}\\,\\mathrm{s}^{-1}$\n\nThe mutant activation rate term is:\n$k_{e, \\mathrm{mut}} [R^{*}] + k_{b, \\mathrm{mut}} = (8.0\\,\\mu\\mathrm{M}^{-1}\\,\\mathrm{s}^{-1})(0.010\\,\\mu\\mathrm{M}) + 1.0 \\times 10^{-3}\\,\\mathrm{s}^{-1} = 0.08\\,\\mathrm{s}^{-1} + 0.001\\,\\mathrm{s}^{-1} = 0.081\\,\\mathrm{s}^{-1}$\n\nThe steady-state concentration for the mutant is:\n$$\n[G_{t}]_{\\mathrm{mut}} = \\frac{(0.081\\,\\mathrm{s}^{-1}) (1.0\\,\\mu\\mathrm{M})}{0.081\\,\\mathrm{s}^{-1} + 0.004\\,\\mathrm{s}^{-1}} = \\frac{0.081}{0.085}\\,\\mu\\mathrm{M}\n$$\n\nThe problem requires the fold-change, $F = [G_{t}]_{\\mathrm{mut}}/[G_{t}]_{\\mathrm{WT}}$.\n$$\nF = \\frac{[G_{t}]_{\\mathrm{mut}}}{[G_{t}]_{\\mathrm{WT}}} = \\frac{\\frac{0.081}{0.085}}{\\frac{0.101}{0.301}} = \\frac{0.081 \\times 0.301}{0.085 \\times 0.101}\n$$\n$$\nF = \\frac{0.024381}{0.008585} \\approx 2.8399534...\n$$\nRounding the result to four significant figures, we get:\n$$\nF \\approx 2.840\n$$\nThe mutation leads to a decrease in the activation rate constant $k_e$ but a much larger decrease in the hydrolysis rate constant $k_h$. The drastic reduction in deactivation more than compensates for the modest reduction in activation, resulting in a significantly higher steady-state level of active G protein.", "answer": "$$\\boxed{2.840}$$", "id": "2947630"}, {"introduction": "To understand how a cell responds to varying concentrations of a ligand, we must link the upstream event of receptor binding to the downstream activation of G proteins. This practice challenges you to construct a complete dose–response model from first principles, integrating the thermodynamics of receptor-ligand equilibrium with the kinetics of the G protein catalytic cycle. This hands-on problem will equip you with the skills to derive and interpret key pharmacological parameters like the half-maximal effective concentration ($\\mathrm{EC}_{50}$) and operational efficacy ($\\tau$), bridging the gap between molecular mechanism and physiological response.", "problem": "You are asked to formalize and compute dose–response characteristics for a minimal, operational model of a G protein-coupled receptor (GPCR) that signals via a heterotrimeric G protein. Build your derivation and implementation strictly from fundamental laws of mass action, conservation of mass, and steady-state analysis.\n\nBase assumptions and definitions:\n- Ligand binding: A ligand $L$ reversibly binds a receptor $R$ to form $RL$ with dissociation constant $K_D$. The system is in a well-mixed compartment. The ligand is buffered by a large reservoir, so the free ligand concentration equals the applied concentration $[L]$ at all times. At equilibrium under mass action and in the buffered-ligand limit, $[RL]$ is determined by $[R]_T$, $K_D$, and $[L]$.\n- G protein activation cycle: Only the ligand-bound receptor $RL$ catalyzes the activation of heterotrimeric G protein $G$ into active $G^\\ast$ (for example, $G\\alpha\\text{-GTP}$), with a second-order catalytic rate constant $k_{\\text{act}}$ such that the activation term is $k_{\\text{act}}\\,[RL]\\,[G]$. Active $G^\\ast$ returns to the inactive pool $G$ via GTP hydrolysis with first-order rate constant $k_{\\text{hyd}}$. Total G protein is conserved: $[G]_T = [G] + [G^\\ast]$. The system is analyzed at steady state.\n- Effect readout: The measurable effect $E([L])$ is a saturating hyperbolic function of $[G^\\ast]$, given by $E([L]) = \\dfrac{[G^\\ast]}{[G^\\ast] + K_E}$, where $K_E$ is a positive constant that sets the sensitivity of the downstream readout.\n- Units: Concentrations are in molar (M), time is in seconds (s). Report any required outputs explicitly in the units specified below.\n\nQuantities to compute:\n- Define the asymptotic maximum effect under saturating ligand as $E_{\\infty} = \\lim_{[L]\\to\\infty} E([L])$.\n- Define the half-maximal effective concentration $\\mathrm{EC}_{50}$ as the ligand concentration $[L]$ that satisfies $E([L]) = \\tfrac{1}{2}\\,E_{\\infty}$. You must report $\\mathrm{EC}_{50}$ in M (molar).\n- Define the dimensionless operational efficacy as follows. Let $\\alpha = [L]/K_D$ be the dimensionless agonist concentration. Define\n$$\n\\tau \\equiv \\frac{1}{E_{\\infty}}\\,\\left.\\frac{dE}{d\\alpha}\\right|_{\\alpha \\to 0^+}.\n$$\nCompute $\\tau$ numerically from first principles without assuming any specific closed-form dose–response model.\n\nImplementation requirements:\n- Derive $E([L])$ from the assumptions using mass-action kinetics and steady-state analysis. Then numerically obtain $E_{\\infty}$, $\\mathrm{EC}_{50}$, and $\\tau$ for each parameter set below.\n- For $\\tau$, evaluate the derivative with respect to $\\alpha$ in the limit $\\alpha \\to 0^+$ numerically with a small positive increment of $\\alpha$.\n- For $\\mathrm{EC}_{50}$, solve $E([L]) = \\tfrac{1}{2}\\,E_{\\infty}$ numerically. Ensure your method works robustly across all parameter sets.\n- Rounding and units: Report $\\mathrm{EC}_{50}$ in M (molar) and $\\tau$ as dimensionless. Round both $\\mathrm{EC}_{50}$ and $\\tau$ to three significant figures.\n\nTest suite (concentrations in M, rate constants in the indicated units):\n- Case 1 (general): $K_D = 5\\times 10^{-8}$, $[R]_T = 2\\times 10^{-9}$, $[G]_T = 1\\times 10^{-7}$, $k_{\\text{act}} = 1\\times 10^{7}\\ \\text{M}^{-1}\\text{s}^{-1}$, $k_{\\text{hyd}} = 1\\times 10^{-1}\\ \\text{s}^{-1}$, $K_E = 3\\times 10^{-8}$.\n- Case 2 (high receptor reserve/efficacy): $K_D = 1\\times 10^{-7}$, $[R]_T = 5\\times 10^{-8}$, $[G]_T = 1\\times 10^{-7}$, $k_{\\text{act}} = 5\\times 10^{7}\\ \\text{M}^{-1}\\text{s}^{-1}$, $k_{\\text{hyd}} = 5\\times 10^{-2}\\ \\text{s}^{-1}$, $K_E = 1\\times 10^{-8}$.\n- Case 3 (low efficacy): $K_D = 2\\times 10^{-8}$, $[R]_T = 2\\times 10^{-9}$, $[G]_T = 5\\times 10^{-8}$, $k_{\\text{act}} = 2\\times 10^{6}\\ \\text{M}^{-1}\\text{s}^{-1}$, $k_{\\text{hyd}} = 1\\times 10^{0}\\ \\text{s}^{-1}$, $K_E = 3\\times 10^{-8}$.\n- Case 4 (G protein limited): $K_D = 1\\times 10^{-8}$, $[R]_T = 5\\times 10^{-7}$, $[G]_T = 5\\times 10^{-9}$, $k_{\\text{act}} = 1\\times 10^{7}\\ \\text{M}^{-1}\\text{s}^{-1}$, $k_{\\text{hyd}} = 2\\times 10^{-1}\\ \\text{s}^{-1}$, $K_E = 2\\times 10^{-9}$.\n\nFinal output format:\n- Your program should produce a single line of output containing the results as a comma-separated list enclosed in square brackets. Each test case result should be the two-element list $[\\mathrm{EC}_{50},\\tau]$ using the units and rounding specified above. For example, a valid format with two hypothetical cases would be: $[[1.23\\mathrm{e}{-7},4.56],[7.89\\mathrm{e}{-8},1.01]]$.", "solution": "The problem statement presents a valid, self-contained, and scientifically grounded model of G protein-coupled receptor (GPCR) signaling. It is based on fundamental principles of mass-action kinetics and conservation of mass, which are standard paradigms in molecular systems biology and quantitative pharmacology. The problem is well-posed, with all parameters, variables, and objectives clearly defined. There are no logical contradictions, factual inaccuracies, or unscientific claims. Therefore, a reasoned solution can be derived.\n\nThe derivation proceeds in a sequence of logical steps, beginning with the initial ligand binding event and culminating in the final measurable effect.\n\n**Step 1: Ligand-Receptor Equilibrium**\nThe reversible binding of a ligand $L$ to a receptor $R$ is described by the reaction $L + R \\rightleftharpoons RL$. The dissociation constant, $K_D$, is given by the law of mass action at equilibrium:\n$$K_D = \\frac{[L][R]}{[RL]}$$\nThe total concentration of receptor, $[R]_T$, is conserved: $[R]_T = [R] + [RL]$. By substituting $[R] = [R]_T - [RL]$ into the expression for $K_D$, we solve for the concentration of the active ligand-receptor complex, $[RL]$:\n$$K_D = \\frac{[L]([R]_T - [RL])}{[RL]}$$\n$$K_D [RL] = [L][R]_T - [L][RL]$$\n$$[RL](K_D + [L]) = [L][R]_T$$\nThis yields the well-known Hill-Langmuir equation, which relates the concentration of the occupied receptor to the free ligand concentration:\n$$[RL] = \\frac{[R]_T [L]}{K_D + [L]}$$\n\n**Step 2: G Protein Activation Cycle at Steady State**\nThe ligand-bound receptor, $RL$, acts as a catalyst for the activation of the G protein. The active form is denoted $G^\\ast$ and the inactive form is $G$. The rate of activation is given as a second-order reaction: $v_{\\text{act}} = k_{\\text{act}}[RL][G]$. The active protein $G^\\ast$ is inactivated via a first-order process, presumably GTP hydrolysis, with a rate $v_{\\text{hyd}} = k_{\\text{hyd}}[G^\\ast]$.\nThe time evolution of $[G^\\ast]$ is given by the differential equation:\n$$\\frac{d[G^\\ast]}{dt} = v_{\\text{act}} - v_{\\text{hyd}} = k_{\\text{act}}[RL][G] - k_{\\text{hyd}}[G^\\ast]$$\nThe problem specifies analysis at steady state, where $\\frac{d[G^\\ast]}{dt} = 0$. Thus:\n$$k_{\\text{act}}[RL][G] = k_{\\text{hyd}}[G^\\ast]$$\nThe total G protein concentration, $[G]_T$, is conserved: $[G]_T = [G] + [G^\\ast]$. Substituting $[G] = [G]_T - [G^\\ast]$ into the steady-state condition gives:\n$$k_{\\text{act}}[RL]([G]_T - [G^\\ast]) = k_{\\text{hyd}}[G^\\ast]$$\nSolving for the steady-state concentration of active G protein, $[G^\\ast]$, as a function of $[RL]$:\n$$k_{\\text{act}}[RL][G]_T = (k_{\\text{hyd}} + k_{\\text{act}}[RL])[G^\\ast]$$\n$$[G^\\ast] = \\frac{k_{\\text{act}}[RL][G]_T}{k_{\\text{hyd}} + k_{\\text{act}}[RL]}$$\nThis equation has the functional form of a Michaelis-Menten relation where $[RL]$ acts as the input signal.\n\n**Step 3: Derivation of the Full Dose-Response Function for $[G^\\ast]$**\nBy substituting the expression for $[RL]$ from Step 1 into the steady-state expression for $[G^\\ast]$ from Step 2, we obtain the relationship between the applied ligand concentration $[L]$ and the amount of active G protein $[G^\\ast]$:\n$$[G^\\ast] = \\frac{k_{\\text{act}}\\left(\\frac{[R]_T [L]}{K_D + [L]}\\right)[G]_T}{k_{\\text{hyd}} + k_{\\text{act}}\\left(\\frac{[R]_T [L]}{K_D + [L]}\\right)}$$\nTo simplify this complex fraction, we multiply the numerator and denominator by $(K_D + [L])$:\n$$[G^\\ast]([L]) = \\frac{k_{\\text{act}}[R]_T [L][G]_T}{k_{\\text{hyd}}(K_D + [L]) + k_{\\text{act}}[R]_T [L]}$$\nRearranging the denominator by powers of $[L]$ yields the final functional form:\n$$[G^\\ast]([L]) = \\frac{k_{\\text{act}}[R]_T [G]_T [L]}{k_{\\text{hyd}}K_D + (k_{\\text{hyd}} + k_{\\text{act}}[R]_T)[L]}$$\n\n**Step 4: Calculation of the Measurable Effect, $E([L])$, and its Maximum, $E_{\\infty}$**\nThe measured effect $E$ is a saturating hyperbolic function of $[G^\\ast]$:\n$$E([L]) = \\frac{[G^\\ast]([L])}{[G^\\ast]([L]) + K_E}$$\nThe maximum effect, $E_{\\infty}$, occurs at a saturating ligand concentration, i.e., in the limit $[L] \\to \\infty$. First, we determine the maximum concentration of active G protein, $[G^\\ast]_{\\infty}$:\n$$[G^\\ast]_{\\infty} = \\lim_{[L]\\to\\infty} [G^\\ast]([L]) = \\lim_{[L]\\to\\infty} \\frac{k_{\\text{act}}[R]_T [G]_T [L]}{k_{\\text{hyd}}K_D + (k_{\\text{hyd}} + k_{\\text{act}}[R]_T)[L]}$$\nDividing numerator and denominator by $[L]$:\n$$[G^\\ast]_{\\infty} = \\frac{k_{\\text{act}}[R]_T [G]_T}{\\lim_{[L]\\to\\infty}\\frac{k_{\\text{hyd}}K_D}{[L]} + (k_{\\text{hyd}} + k_{\\text{act}}[R]_T)} = \\frac{k_{\\text{act}}[R]_T [G]_T}{k_{\\text{hyd}} + k_{\\text{act}}[R]_T}$$\nThe maximum effect $E_{\\infty}$ is then:\n$$E_{\\infty} = \\frac{[G^\\ast]_{\\infty}}{[G^\\ast]_{\\infty} + K_E}$$\n\n**Step 5: Calculation of Half-Maximal Effective Concentration, $\\mathrm{EC}_{50}$**\nThe $\\mathrm{EC}_{50}$ is the ligand concentration $[L]$ at which the effect is half of its maximum: $E(\\mathrm{EC}_{50}) = \\frac{1}{2}E_{\\infty}$. We must solve this equation for $[L]=\\mathrm{EC}_{50}$. Let $[G^\\ast]_{\\mathrm{EC50}}$ be the concentration of active G protein at $\\mathrm{EC}_{50}$. The condition becomes:\n$$\\frac{[G^\\ast]_{\\mathrm{EC50}}}{[G^\\ast]_{\\mathrm{EC50}} + K_E} = \\frac{1}{2} \\left( \\frac{[G^\\ast]_{\\infty}}{[G^\\ast]_{\\infty} + K_E} \\right)$$\nSolving this for $[G^\\ast]_{\\mathrm{EC50}}$ yields:\n$$[G^\\ast]_{\\mathrm{EC50}} = \\frac{K_E [G^\\ast]_{\\infty}}{[G^\\ast]_{\\infty} + 2K_E}$$\nWe must then invert the dose-response function $[G^\\ast]([L])$ to find the corresponding $[L]$ which is $\\mathrm{EC}_{50}$. This requires solving $[G^\\ast]([L])=[G^\\ast]_{\\mathrm{EC50}}$ for $[L]$. Given the monotonic nature of the function, a numerical root-finding algorithm, such as the bisection method, is suitable and robust. The equation to solve is $E([L]) - \\frac{1}{2} E_{\\infty} = 0$.\n\n**Step 6: Calculation of Operational Efficacy, $\\tau$**\nThe operational efficacy $\\tau$ is defined as $\\tau \\equiv \\frac{1}{E_{\\infty}}\\,\\left.\\frac{dE}{d\\alpha}\\right|_{\\alpha \\to 0^+}$, where $\\alpha = [L]/K_D$.\nWe use the chain rule: $\\frac{dE}{d\\alpha} = \\frac{dE}{d[G^\\ast]} \\frac{d[G^\\ast]}{d[L]} \\frac{d[L]}{d\\alpha}$.\nFirst, $\\frac{d[L]}{d\\alpha} = K_D$.\nSecond, $\\frac{dE}{d[G^\\ast]} = \\frac{K_E}{([G^\\ast] + K_E)^2}$. In the limit $\\alpha \\to 0^+$, $[L] \\to 0^+$ and $[G^\\ast] \\to 0$. Thus, $\\lim_{\\alpha \\to 0^+} \\frac{dE}{d[G^\\ast]} = \\frac{1}{K_E}$.\nThird, $\\frac{d[G^\\ast]}{d[L]} = \\frac{d}{d[L]} \\left( \\frac{A [L]}{B + C [L]} \\right) = \\frac{A B}{(B + C [L])^2}$, where $A=k_{\\text{act}}[R]_T [G]_T$, $B=k_{\\text{hyd}}K_D$, and $C=k_{\\text{hyd}} + k_{\\text{act}}[R]_T$.\nIn the limit $[L] \\to 0$, this derivative becomes $\\frac{A B}{B^2} = \\frac{A}{B} = \\frac{k_{\\text{act}}[R]_T [G]_T}{k_{\\text{hyd}}K_D}$.\nCombining the terms:\n$$\\left.\\frac{dE}{d\\alpha}\\right|_{\\alpha \\to 0^+} = \\left(\\frac{1}{K_E}\\right) \\left(\\frac{k_{\\text{act}}[R]_T [G]_T}{k_{\\text{hyd}}K_D}\\right) (K_D) = \\frac{k_{\\text{act}}[R]_T [G]_T}{k_{\\text{hyd}}K_E}$$\nThus, the analytical form for $\\tau$ is:\n$$\\tau = \\frac{1}{E_{\\infty}} \\left( \\frac{k_{\\text{act}}[R]_T [G]_T}{k_{\\text{hyd}}K_E} \\right)$$\nAs per the problem, this will be computed numerically using a finite difference approximation for a small increment of $\\alpha$:\n$$\\left.\\frac{dE}{d\\alpha}\\right|_{\\alpha \\to 0^+} \\approx \\frac{E(\\alpha=\\delta) - E(\\alpha=0)}{\\delta} = \\frac{E(\\alpha=\\delta)}{\\delta}$$\nwhere $\\delta$ is a small positive number.\n\nThe implementation will follow these derivations to compute the required quantities for each test case.", "answer": "```python\nimport numpy as np\nimport scipy.optimize\nimport math\n\ndef solve():\n    \"\"\"\n    Computes dose-response characteristics (EC50, tau) for a GPCR model.\n    \"\"\"\n\n    test_cases = [\n        # Case 1 (general)\n        {\"K_D\": 5e-8, \"R_T\": 2e-9, \"G_T\": 1e-7, \"k_act\": 1e7, \"k_hyd\": 1e-1, \"K_E\": 3e-8},\n        # Case 2 (high receptor reserve/efficacy)\n        {\"K_D\": 1e-7, \"R_T\": 5e-8, \"G_T\": 1e-7, \"k_act\": 5e7, \"k_hyd\": 5e-2, \"K_E\": 1e-8},\n        # Case 3 (low efficacy)\n        {\"K_D\": 2e-8, \"R_T\": 2e-9, \"G_T\": 5e-8, \"k_act\": 2e6, \"k_hyd\": 1.0, \"K_E\": 3e-8},\n        # Case 4 (G protein limited)\n        {\"K_D\": 1e-8, \"R_T\": 5e-7, \"G_T\": 5e-9, \"k_act\": 1e7, \"k_hyd\": 2e-1, \"K_E\": 2e-9},\n    ]\n\n    def round_to_sf(x, sf):\n        \"\"\"Rounds a number to a specified number of significant figures.\"\"\"\n        if x == 0:\n            return 0.0\n        # Calculate the position of the most significant digit\n        log_val = math.log10(abs(x))\n        round_pos = sf - 1 - int(math.floor(log_val))\n        return round(x, round_pos)\n\n    def calculate_metrics(params):\n        \"\"\"\n        Calculates EC50 and tau for a given set of parameters.\n        \"\"\"\n        K_D = params[\"K_D\"]\n        R_T = params[\"R_T\"]\n        G_T = params[\"G_T\"]\n        k_act = params[\"k_act\"]\n        k_hyd = params[\"k_hyd\"]\n        K_E = params[\"K_E\"]\n\n        # Define G_star concentration as a function of ligand concentration L\n        # [G*]([L]) = (k_act * [R]T * [G]T * [L]) / (k_hyd * K_D + (k_hyd + k_act * [R]T) * [L])\n        A = k_act * R_T * G_T\n        B = k_hyd * K_D\n        C = k_hyd + k_act * R_T\n        \n        def get_G_star(L):\n            return (A * L) / (B + C * L)\n\n        # Define Effect E as a function of ligand concentration L\n        def get_E(L):\n            G_star = get_G_star(L)\n            return G_star / (G_star + K_E)\n\n        # 1. Calculate E_infinity\n        G_star_inf = (k_act * R_T * G_T) / (k_hyd + k_act * R_T)\n        E_inf = G_star_inf / (G_star_inf + K_E)\n\n        # 2. Calculate EC50 numerically\n        # EC50 is L where E(L) = 0.5 * E_inf\n        # We solve f(L) = E(L) - 0.5 * E_inf = 0\n        def ec50_objective(L):\n            return get_E(L) - 0.5 * E_inf\n\n        # Find a suitable search bracket [a, b] for the root finder\n        # Since E(L) is monotonic and E(0) < 0.5*E_inf, we know a root exists if E(L) can exceed 0.5*E_inf\n        # The bracket [1e-15, 1.0] should be robust for typical pharmacological concentrations.\n        # E(1e-15) is very close to E(0), so ec50_objective(1e-15) is negative.\n        # E(1.0) is very close to E_inf, so ec50_objective(1.0) is positive.\n        try:\n            ec50 = scipy.optimize.bisect(ec50_objective, 1e-15, 1.0)\n        except ValueError:\n            # This can happen if E_inf is 0 or the function does not cross zero in the interval\n            ec50 = np.nan\n\n        # 3. Calculate tau numerically\n        # tau = (1/E_inf) * dE/d(alpha) at alpha -> 0+\n        # where alpha = L/K_D\n        # We approximate dE/d(alpha) with E(alpha=delta)/delta for a small delta\n        delta_alpha = 1e-9\n        L_delta = delta_alpha * K_D\n        E_delta = get_E(L_delta)\n        \n        if E_inf > 1e-12: # Avoid division by zero if E_inf is effectively zero\n            tau = (1 / E_inf) * (E_delta / delta_alpha)\n        else:\n            tau = 0.0\n\n        return ec50, tau\n\n    results = []\n    for case_params in test_cases:\n        ec50, tau = calculate_metrics(case_params)\n        \n        # Round final numbers to three significant figures as requested\n        ec50_rounded = round_to_sf(ec50, 3)\n        tau_rounded = round_to_sf(tau, 3)\n\n        results.append([ec50_rounded, tau_rounded])\n    \n    # Format the final output string to match the specified format without extra spaces\n    # and with standard python float representation.\n    final_output_str = str(results).replace(\" \", \"\")\n    print(final_output_str)\n\nsolve()\n\n```", "id": "2947595"}, {"introduction": "G protein signaling pathways often exhibit switch-like, ultrasensitive responses, where a small change in an input signal produces a disproportionately large change in the output. This exercise explores a common mechanism for generating such nonlinearity: the cooperative binding of signaling molecules to a downstream effector, such as an ion channel. By deriving the activation function and calculating the effective Hill coefficient for a multi-site channel model, you will see how molecular stoichiometry and binding requirements can give rise to complex and powerful systems-level behaviors.", "problem": "In a canonical heterotrimeric guanine nucleotide-binding protein (G protein) pathway, activation of a G protein-coupled receptor (GPCR) produces free $G\\beta\\gamma$ subunits that bind to and activate a G protein-gated inwardly rectifying potassium channel (GIRK). Consider a simplified, mechanistically faithful model in which the GIRK channel has $4$ identical and independent binding sites for $G\\beta\\gamma$, each with the same equilibrium dissociation constant $K_{d}$ for free $G\\beta\\gamma$ at concentration $x$. Assume rapid equilibrium binding and that the channel is functionally active only when all $4$ sites are occupied.\n\nUsing only the law of mass action, equilibrium binding, and independence of sites as your starting principles, first derive the steady-state fraction of active channels $F(x)$ as a function of $x$ and $K_{d}$. Then, using the definition of the effective Hill coefficient for an input-output map $F(x)$ as\n$$\nn_{H} \\equiv \\left.\\frac{d}{d\\ln x}\\ln\\!\\left(\\frac{F(x)}{1 - F(x)}\\right)\\right|_{F(x)=\\frac{1}{2}},\n$$\ncompute $n_{H}$ at the half-activation point. Express your final answer as a single simplified analytic expression. No numerical approximation is required. The final answer is dimensionless.", "solution": "The problem requires the derivation of the steady-state fraction of active G protein-gated inwardly rectifying potassium (GIRK) channels, $F(x)$, and the subsequent calculation of the effective Hill coefficient, $n_{H}$, at the point of half-maximal activation. The analysis will be based on the principles of mass-action kinetics, equilibrium binding, and the independence of binding sites.\n\nFirst, we derive the expression for $F(x)$.\nLet $S$ represent a single binding site on the GIRK channel for a $G\\beta\\gamma$ subunit, and let $x$ be the concentration of free $G\\beta\\gamma$. The binding of $G\\beta\\gamma$ to a site is a reversible reaction at equilibrium:\n$$\nS + G\\beta\\gamma \\rightleftharpoons S \\cdot G\\beta\\gamma\n$$\nThe equilibrium dissociation constant, $K_{d}$, is defined by the law of mass action:\n$$\nK_{d} = \\frac{[S] [G\\beta\\gamma]}{[S \\cdot G\\beta\\gamma]} = \\frac{[S] x}{[S \\cdot G\\beta\\gamma]}\n$$\nFrom this, we can express the ratio of occupied sites to unoccupied sites:\n$$\n\\frac{[S \\cdot G\\beta\\gamma]}{[S]} = \\frac{x}{K_{d}}\n$$\nThe probability that any given single site is occupied, which we denote as $p_{occ}$, is the fraction of total sites in the occupied state. This is given by:\n$$\np_{occ} = \\frac{[S \\cdot G\\beta\\gamma]}{[S] + [S \\cdot G\\beta\\gamma]} = \\frac{\\frac{[S \\cdot G\\beta\\gamma]}{[S]}}{1 + \\frac{[S \\cdot G\\beta\\gamma]}{[S]}} = \\frac{\\frac{x}{K_{d}}}{1 + \\frac{x}{K_{d}}}\n$$\nMultiplying the numerator and denominator by $K_d$ simplifies this expression to:\n$$\np_{occ}(x) = \\frac{x}{x + K_{d}}\n$$\nThe problem states that the GIRK channel possesses $N=4$ identical and independent binding sites. It is further stipulated that a channel is functionally active only when all $4$ of its sites are occupied by $G\\beta\\gamma$. Since the binding events at each site are independent, the probability that all $4$ sites are simultaneously occupied is the product of the individual probabilities of occupation for each site. Therefore, the fraction of active channels, $F(x)$, is:\n$$\nF(x) = [p_{occ}(x)]^4 = \\left(\\frac{x}{x + K_{d}}\\right)^4\n$$\nThis is the required expression for the steady-state fraction of active channels.\n\nNext, we must compute the effective Hill coefficient, $n_{H}$. The definition is provided as:\n$$\nn_{H} \\equiv \\left.\\frac{d}{d\\ln x}\\ln\\!\\left(\\frac{F(x)}{1 - F(x)}\\right)\\right|_{F(x)=\\frac{1}{2}}\n$$\nTo simplify the calculation, let us introduce the substitution $u(x) = p_{occ}(x) = \\frac{x}{x + K_{d}}$. Then $F(x) = u^4$.\nThe argument of the logarithm is $\\frac{F(x)}{1 - F(x)} = \\frac{u^4}{1 - u^4}$. Let us define $Y(u) = \\ln\\left(\\frac{u^4}{1 - u^4}\\right)$. Using properties of logarithms, we have:\n$$\nY(u) = \\ln(u^4) - \\ln(1 - u^4) = 4\\ln(u) - \\ln(1 - u^4)\n$$\nWe need to compute the derivative of this quantity with respect to $\\ln(x)$. We apply the chain rule:\n$$\nn_{H} = \\frac{dY}{d\\ln x} = \\frac{dY}{du} \\frac{du}{d\\ln x}\n$$\nFirst, let's find the derivative $\\frac{dY}{du}$:\n$$\n\\frac{dY}{du} = \\frac{d}{du}\\left(4\\ln(u) - \\ln(1 - u^4)\\right) = \\frac{4}{u} - \\frac{-4u^3}{1 - u^4} = \\frac{4(1-u^4) + 4u^4}{u(1-u^4)} = \\frac{4}{u(1-u^4)}\n$$\nNext, let's find the derivative $\\frac{du}{d\\ln x}$. We again use the chain rule: $\\frac{du}{d\\ln x} = x \\frac{du}{dx}$.\n$$\n\\frac{du}{dx} = \\frac{d}{dx}\\left(\\frac{x}{x + K_{d}}\\right) = \\frac{(1)(x+K_d) - (x)(1)}{(x+K_d)^2} = \\frac{K_d}{(x+K_d)^2}\n$$\nSo,\n$$\n\\frac{du}{d\\ln x} = x \\left(\\frac{K_d}{(x+K_d)^2}\\right) = \\frac{x}{x+K_d} \\frac{K_d}{x+K_d} = u(1-u)\n$$\nwhere we have used the fact that $1 - u = 1 - \\frac{x}{x+K_d} = \\frac{K_d}{x+K_d}$.\n\nNow we can combine these results to find the expression for $n_H$:\n$$\nn_{H} = \\frac{dY}{du} \\frac{du}{d\\ln x} = \\left(\\frac{4}{u(1-u^4)}\\right) \\left(u(1-u)\\right) = \\frac{4(1-u)}{1-u^4}\n$$\nThe denominator can be factored as a difference of squares: $1-u^4 = (1-u^2)(1+u^2) = (1-u)(1+u)(1+u^2)$.\nThus, the expression for $n_{H}$ simplifies to:\n$$\nn_{H}(u) = \\frac{4(1-u)}{(1-u)(1+u)(1+u^2)} = \\frac{4}{(1+u)(1+u^2)}\n$$\nThis expression must be evaluated at the specific point where $F(x) = \\frac{1}{2}$.\nThe condition $F(x) = u^4 = \\frac{1}{2}$ implies that $u = \\left(\\frac{1}{2}\\right)^{1/4} = 2^{-1/4}$.\nWe do not need to find the specific value of $x$ for which this occurs. We only need the value of $u$.\n\nAn alternative, more direct path for evaluation is to return to the un-simplified expression $n_{H} = \\frac{4(1-u)}{1-u^4}$. At the point of interest, we know $u^4 = \\frac{1}{2}$. Substituting this directly:\n$$\nn_{H} = \\frac{4(1-u)}{1 - \\frac{1}{2}} = \\frac{4(1-u)}{\\frac{1}{2}} = 8(1-u)\n$$\nNow we substitute the value $u = 2^{-1/4}$:\n$$\nn_{H} = 8(1 - 2^{-1/4})\n$$\nThis is the final, simplified analytic expression for the Hill coefficient at half-maximal activation for the given model. It is a dimensionless quantity, as expected.", "answer": "$$\\boxed{8 \\left(1 - 2^{-1/4}\\right)}$$", "id": "2947620"}]}